Currently, there are four main treatments propelling this market forward: Ozempic and Wegovy (semaglutide: a GLP-1 agonist, developed by Novo Nordisk) Mounjaro and Zepbound (tirzepatide: a dual agonist targeting both GLP-1 and GIP (Gastric inhibitory polypeptide) receptors, developed by Eli Lilly) These medications are administered subcutaneously with the assistance of injection pens
And part of improving health is being more physically active and eating a healthier diet things most of us need to do
most patients secure appointments within 24 hours, making us a premier choice for those seeking tirzepatide treatment in Lakewood
Whether you are managing type 2 diabetes or beginning a medically supported weight management plan, MedsRus provides a clinically safe route to treatment
Semaglutide has years of large studies showing it lowers the risk of serious heart events and helps protect the kidneys in people with type 2 diabetes
Semaglutide pens should be kept in the refrigerator until you are ready to use them